KENGREAL

Peak

cangrelor

NDAINTRAVENOUSPOWDER

Approved

Jun 2015

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

P2Y12 Receptor Antagonists

Pharmacologic Class:

P2Y12 Platelet Inhibitor

Loss of Exclusivity

LOE Date

Jul 10, 2035

113 months away

Patent Expiry

Jul 10, 2035

Patent Records (5)

Patent #	Expiry	Type	Use Code
9925265	May 13, 2029		U-2260
9427448	Nov 10, 2030		U-1926
8680052	Mar 9, 2033		U-2979
9295687	Jul 10, 2035	Product	—
10039780	Jul 10, 2035		U-2260

Company

Brazil - Santana de Parnaíba

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers